Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

European Magnetic Resonance Imaging in MS Group celebrates 20 years

Group of people standing outside Wolfson College for a posed photo.

The European Magnetic Resonance Imaging in MS group (MAGNIMS) consists of nine different centres, collaborating on research and expert guidelines in the field. 

Our Neuromyelitis Optica and Multiple Sclerosis teams hosted a very successful 37th meeting of the MAGNIMS group at Wolfson College Oxford in May 2022, which marked 20 years of this collaboration. Sponsorship from UCB, Roche and Alexion made it possible.

The workshop topic was 'Identifying imaging features of MOG Antibody Disease (MOGAD) and differentiating it from MS : towards producing MOGAD imaging criteria'. This fits in with Oxford's highly specialised expertise in MOGAD and Neuromyelitis Optica. Experts in pathology and neuroimmunology as well as imaging participated, with speakers from Europe and the US. A review publication from the workshop is now planned.

The meeting was fully subscribed with 80 in-person participants and 30 people joining online. Ruth Geraldes and Silvia Messina provided a punting lesson for delegates. A celebratory cake included a model brain, although the two pathologists were not impressed!  

Similar stories

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

Celebrating NDCN at Thomas Willis Day 2026

Our annual event where we join together to celebrate our people and the work of our Department over the last year. Nearly 250 staff and students came together for this year's event on Tuesday 16 June at the Mathematical Institute.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.